Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
decrease risks » increased risks (Expand Search), disease risks (Expand Search), decrease rice (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 101 - 120 results of 25,979 for search '(( significantly ((greater decrease) OR (mean decrease)) ) OR ( significant decrease risks ))', query time: 1.78s Refine Results
  1. 101
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 102
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 103
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 104
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 105
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 106
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 107
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 108
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 109
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 110
    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up by gender (<i>n</i> = 662).

    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up by gender (<i>n</i> = 662). by Maria Anna Donati (6735548)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 111
    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test by gender (<i>n</i> = 900).

    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test by gender (<i>n</i> = 900). by Maria Anna Donati (6735548)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 112
    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test by age groups (<i>n</i> = 900).

    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test by age groups (<i>n</i> = 900). by Maria Anna Donati (6735548)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 113
    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up by age group (<i>n</i> = 662).

    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up by age group (<i>n</i> = 662). by Maria Anna Donati (6735548)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 114
    <i>Ctsz</i><sup><i>−/−</i></sup> mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.

    <i>Ctsz</i><sup><i>−/−</i></sup> mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.... by Rachel K. Meade (22216529)

    Published 2025
    Save to List
    Saved in:
  15. 115
    Forest plots illustrate the mean difference in; (A) hospital stay, (B) ICU stay, (C) intubation time; with subgroup analysis.

    Forest plots illustrate the mean difference in; (A) hospital stay, (B) ICU stay, (C) intubation time; with subgroup analysis. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 116
    Decreased frequency of CD8+ cells and M1/M2 macrophage ratio in obese mice might indicate an impaired anti-tumoral reponse.

    Decreased frequency of CD8+ cells and M1/M2 macrophage ratio in obese mice might indicate an impaired anti-tumoral reponse. by Aleida Núñez-Ruiz (12463062)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 117
    Characteristics of patients with AKI diagnosed using KDIGO definition versus patients diagnosed with AKI by eKDIGO only by the decrease in sCr (deKDIGO).

    Characteristics of patients with AKI diagnosed using KDIGO definition versus patients diagnosed with AKI by eKDIGO only by the decrease in sCr (deKDIGO). by Marina Wainstein (12437091)

    Published 2022
    Save to List
    Saved in:
  18. 118
    Logistic regression: Risk factors for PTB <35w in subsequent delivery.

    Logistic regression: Risk factors for PTB <35w in subsequent delivery. by Gal Cohen (12536546)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 119
    Risk Classification Diagram of Hot Surface.

    Risk Classification Diagram of Hot Surface. by Lei Bai (631944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 120
    Assessing model fit.

    Assessing model fit. by Jess A. Millar (2635135)

    Published 2021
    Subjects:
    Save to List
    Saved in:

Search Tools: